Oramed Pharmaceuticals Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	2019 - 2015
Period Ending	Feb '25 Feb 20, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Aug '21 Aug 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Market Capitalization	309	336	1,655	1,692	2,051	355	Upgrade
Market Cap Growth	-7.77%	-79.72%	-2.19%	-17.53%	477.70%	28.87%	Upgrade
Enterprise Value	-202	-33	1,094	1,382	1,810	214	Upgrade
Last Close Price	8.21	8.20	38.83	40.80	63.30	13.77	Upgrade
PE Ratio	18.61	16.87	-	-	-	-	Upgrade
PS Ratio	-	69.54	174.08	200.54	236.73	40.73	Upgrade
PB Ratio	0.64	0.57	3.11	3.26	5.49	-	Upgrade
P/TBV Ratio	0.64	0.57	3.10	3.27	5.53	-	Upgrade
EV/Sales Ratio	-	-	115.15	163.83	208.87	24.59	Upgrade
EV/FCF Ratio	6.86	-	-	-	-	-	Upgrade
Debt / Equity Ratio	0.00	0.32	0.01	0.00	0.00	-	Upgrade
Asset Turnover	-	0.01	0.02	-	0.03	-	Upgrade
Quick Ratio	26.99	3.05	27.10	19.85	14.09	-	Upgrade
Current Ratio	27.08	3.06	27.34	20.08	14.27	-	Upgrade
Return on Equity (ROE)	2.89%	3.24%	-23.77%	-	-30.78%	-	Upgrade
Return on Assets (ROA)	-4.12%	-5.16%	-14.95%	-	-17.54%	-	Upgrade
Return on Capital (ROIC)	-4.29%	-5.38%	-15.90%	-	-20.19%	-	Upgrade
Earnings Yield	5.37%	5.93%	-7.77%	-6.44%	-3.48%	-19.89%	Upgrade
FCF Yield	-9.54%	-11.32%	-6.04%	-6.14%	-3.37%	-23.31%	Upgrade
Buyback Yield / Dilution	-2.51%	-4.02%	-5.08%	-30.36%	-16.71%	-18.81%	Upgrade
Total Shareholder Return	-2.51%	-4.02%	-5.08%	-30.36%	-16.71%	-18.81%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.